March 08, 2011; 76 (10) Clinical/Scientific Notes
Rituximab monotherapy for patients with recurrent primary CNS lymphoma
T.T. Batchelor, S.A. Grossman, T. Mikkelsen, X. Ye, S. Desideri, G.J. Lesser
First published March 7, 2011, DOI: https://doi.org/10.1212/WNL.0b013e31820f2d94
T.T. Batchelor
S.A. Grossman
T. Mikkelsen
X. Ye
S. Desideri
Rituximab monotherapy for patients with recurrent primary CNS lymphoma
T.T. Batchelor, S.A. Grossman, T. Mikkelsen, X. Ye, S. Desideri, G.J. Lesser
Neurology Mar 2011, 76 (10) 929-930; DOI: 10.1212/WNL.0b013e31820f2d94
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 76 no. 10 929-930
PubMed:
Print ISSN:
Online ISSN:
History:
- Received May 21, 2010
- Accepted September 24, 2010
- First Published March 7, 2011.
Copyright & Usage:
Copyright © 2011 by AAN Enterprises, Inc.
Author Disclosures
- T.T. Batchelor, MD,
- S.A. Grossman, MD,
- T. Mikkelsen, MD,
- X. Ye, PhD,
- S. Desideri, MD and
- G.J. Lesser, MD
- T.T. Batchelor, MD,
- S.A. Grossman, MD,
- T. Mikkelsen, MD,
- X. Ye, PhD,
- S. Desideri, MD and
- G.J. Lesser, MD
- From the Departments of Neurology and Radiation Oncology, Division of Hematology and Oncology (T.T.B.), Massachusetts General Hospital, Boston; Department of Oncology (S.A.G., X.Y., S.D.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurosurgery (T.M.), Henry Ford Hospital, Detroit, MI; and Department of Medicine (G.J.L.), Wake Forest University Medical Center, Winston-Salem, NC.
- Address correspondence and reprint requests to Dr. Tracy Batchelor, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Yawkey 9E, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114; tbatchelor{at}partners.org
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphomaMatthias Holdhoff, Prakash Ambady, Ahmed Abdelaziz et al.Neurology, June 13, 2014 -
Article
Management and outcome of primary CNS lymphoma in the modern eraAn LOC network studyCaroline Houillier, Carole Soussain, Hervé Ghesquières et al.Neurology, January 06, 2020 -
Articles
Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphomaAndreas F. Hottinger, Lisa M. DeAngelis, Joachim Yahalom et al.Neurology, September 10, 2007 -
Brief Communications
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomideRoelien H. Enting, Alexis Demopoulos, Lisa M. DeAngelis et al.Neurology, September 13, 2004